Recent reports have shown the oncogenic role of PBX3 in hematological malignancies and a variety of solid tumors, including acute myeloid leukemia, gastric cancer, colorectal cancer, liver cancer, and cervical cancer 18-22. Here, PBX3 is linked to cervical carcinoma.